Dear Sir/Madam, Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors in its meeting held on Thursday, July 21, 2022 have inter alia, transacted the following businesses: 1. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the un-audited standalone and consolidated financial results for the quarter ended June 30, 2022 along with Limited Review Report issued by M/s. S. C Mehra & Associates LLP Ltd, Statutory Auditors of the Company as approved by Board of Directors 2. Declaration of Interim Dividend 3.Increase in Authorised Share Capital of the Company and amendment in MOA 4. Rights Issue 5.Intimation of Recommendation of Appointment of Mr. Ranjeet Singh Rana (DIN: 09675082), as Independent Director of the Company.